Renin-angiotensin system blockade is not associated with hyperkalemia in chronic hemodialysis patients

Renal Failure

Volumn 31, Issue 10, 2009, Pages 942-945

  Lin, Hsin Hung ^a   Yang, Ya Fei ^a   Chang, Ju Kuang ^a   Ting, I Wen ^a   Kuo, Huey Liang ^a   Wang, I Kuan ^a   Huang, Chiu Ching ^a  

^a CHINA MEDICAL UNIVERSITY HOSPITAL   (Taiwan)

Author keywords

ACE I; ARB; Hemodialysis; Hyperkalemia; RASB

Indexed keywords

ACETYLSALICYLIC ACID; ANGIOTENSIN RECEPTOR ANTAGONIST; ANTICOAGULANT AGENT; BETA ADRENERGIC RECEPTOR BLOCKING AGENT; CALCIUM CHANNEL BLOCKING AGENT; CHINESE DRUG; DIGOXIN; DIPEPTIDYL CARBOXYPEPTIDASE INHIBITOR; DIURETIC AGENT; FUROSEMIDE; HEPARIN; HERBACEOUS AGENT; INSULIN; LOW MOLECULAR WEIGHT HEPARIN; NONSTEROID ANTIINFLAMMATORY AGENT; ORAL ANTIDIABETIC AGENT; POTASSIUM;

ADULT; ARTICLE; CARDIOVASCULAR DISEASE; CHRONIC KIDNEY DISEASE; DIABETES MELLITUS; DIALYSATE; FEMALE; HEMODIALYSIS PATIENT; HUMAN; HYPERKALEMIA; KIDNEY FAILURE; LOGISTIC REGRESSION ANALYSIS; MAJOR CLINICAL STUDY; MALE; MULTIVARIATE ANALYSIS; POTASSIUM BLOOD LEVEL; PRIORITY JOURNAL; RENIN ANGIOTENSIN ALDOSTERONE SYSTEM; TREATMENT DURATION;

ADULT; AGED; ANGIOTENSIN II TYPE 1 RECEPTOR BLOCKERS; ANGIOTENSIN-CONVERTING ENZYME INHIBITORS; CROSS-SECTIONAL STUDIES; FEMALE; HUMANS; HYPERKALEMIA; KIDNEY FAILURE, CHRONIC; MALE; MIDDLE AGED; RENIN-ANGIOTENSIN SYSTEM;

EID: 73649117466     PISSN: 0886022X     EISSN: 15256049     Source Type: Journal    
DOI: 10.3109/08860220903216147     Document Type: Article

References (8)

1. Tzamaloukas AH, Avasthi PS. Temporal profile of serum potassium concentration in nondiabetic and diabetic outpatients on chronic dialysis. Am J Nephrol. 1897;7:101-109.
2. Morduchowicz G, Winkler J, Drazne E, Van Dyk DJ, Wittenberg C, Zabludowski JR, Shohat J, Rosendfeld JB, Boner G. Causes of death in patients with end-stage renal disease treated by dialysis in a center in Israel. Isr J Med Sci. 1992;28:776-779.
3. Shibata M, Kishi T, Iwata H. Clinical study of complications in dialyzed diabetics. Tohoku J Exp Med. 1983;141:417-425.
4. Knoll GA, Sahgal A, Nair RC, Graham J, van Walraven C, Burns KD. Renin-angiotensin system blockade and the risk of hyperkalemia in chronic hemodialysis patients. Am J Med. 2002;112:110-114.
5. Han SW, Won YW, Yi JH, Kim HJ. No impact of hyperkalemia with rennin-angiotensin system blockades in maintenance hemodialysis patients. Nephrol Dial Transplant. 2007;22(4): 1150-1155.
6. Junaid A, Lawrence SW. Hyperkalemia in dialysis patients. Seminars in Dialysis. 2001;14(5):348-356.
7. Allon M. Treatment and prevention of hyperkalemia in endstage renal disease. Kidney Int. 1993;43:1197-1209.
8. Sugarman A, Brown RS. The role of aldosterone in potassium tolerance: Studies in anephric patients. Kidney Int. 1988;34: 397-403.